Domesco Medical Import - Export Joint-Stock Corporation (HOSE:DMC)
Vietnam · Delayed Price · Currency is VND 57,800
-100 (-0.17%)
At close: Jul 24, 2026
HOSE:DMC Financials Overview
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 2,117,779 | 2,067,317 | 1,899,427 | 1,719,032 | 1,592,727 | 1,498,395 |
Revenue Growth | 8.64% | 8.84% | 10.49% | 7.93% | 6.30% | 3.20% |
Gross Profit Gross Profit Growth | 413,176 | 409,108 | 417,480 | 372,101 | 452,889 | 401,616 |
Operating Income Operating Income Growth | 231,557 | 220,800 | 226,028 | 183,443 | 234,484 | 186,405 |
Net Income Net Income Growth | 173,653 | 168,638 | 172,301 | 164,999 | 170,064 | 143,354 |
Earnings Per Share EPS Growth | 5000.00 | 4856.00 | 4961.51 | 4751.00 | 4897.00 | 4127.96 |
EPS Growth | -2.15% | -2.13% | 4.43% | -2.98% | 18.63% | -11.28% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 579,932 | 567,142 | 403,950 | 589,561 | 452,704 | 310,620 |
Total Debt Total Debt Growth | - | - | - | - | - | - |
Net Cash (Debt) Net Cash Growth | 579,932 | 567,142 | 403,950 | 589,561 | 452,704 | 310,620 |
Net Cash Growth | 55.12% | 40.40% | -31.48% | 30.23% | 45.74% | 33.45% |
Net Cash Per Share Net Cash Per Share Growth | 16699.52 | 16331.23 | 11632.00 | 16976.81 | 13035.90 | 8944.51 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 161,438 | 161,354 | 15,687 | 148,913 | 273,689 | 162,445 |
Capital Expenditures CapEx Growth | -24,518 | -36,697 | -41,612 | -7,301 | -10,565 | -6,114 |
Free Cash Flow Free Cash Flow Growth | 136,920 | 124,657 | -25,925 | 141,611 | 263,124 | 156,331 |
Free Cash Flow Growth | - | - | - | -46.18% | 68.31% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 19.51% | 19.79% | 21.98% | 21.65% | 28.43% | 26.80% |
Operating Margin | 10.93% | 10.68% | 11.90% | 10.67% | 14.72% | 12.44% |
Pretax Margin | 12.06% | 12.00% | 13.34% | 13.33% | 15.71% | 13.29% |
Profit Margin | 8.20% | 8.16% | 9.07% | 9.60% | 10.68% | 9.57% |
FCF Margin | 6.46% | 6.03% | -1.36% | 8.24% | 16.52% | 10.43% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 2500.000 | - | 2500.000 | 2500.000 | 2500.000 | 2500.000 |
Dividend Per Share Growth | 0% | - | 0% | 0% | 0% | 0% |
Dividend Yield | 4.32% | - | 3.77% | 4.69% | 6.80% | 5.60% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 10.31 | 12.29 | 13.91 | 12.10 | 8.39 | 12.72 |
Forward PE | - | 9.47 | 9.47 | 9.47 | 9.47 | 9.47 |
P/FCF Ratio | 46.17 | 16.63 | - | 14.10 | 5.42 | 11.66 |
PS Ratio | 0.94 | 1.00 | 1.26 | 1.16 | 0.90 | 1.22 |